ORGO · Organogenesis Holdings Inc. · Proposed Sales
Market Cap
$191.73M
Shares
128.67M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-16 | Glenn Nussdorf | Director, Stakeholder | 200,000 | 2025-12-16 | UBS Financial Services Inc |
| 2025-11-25 | Glenn Nussdorf | Director, Stakeholder | 200,000 | 2025-11-25 | UBS Financial Services Inc |
| 2025-11-24 | Glenn Nussdorf | Director, Stakeholder | 100,000 | 2025-11-24 | UBS Financial Services Inc |
| 2025-03-17 | Driscoll Michael Joseph | Director | 25,000 | 2025-03-04 | Merrill Lynch |
| 2024-12-06 | Gillheeney Gary S. | Officer | 380,000 | 2024-12-06 | Merrill Lynch |
| 2024-01-09 | RED Holdings, LLC | Shareholder is part of a control group | 2,000,000 | 2024-01-09 | UBS Financial Services Inc |
| 2024-01-09 | Albert Erani | Part of a control group of shareholders | 422,589 | 2024-01-09 | UBS Financial Services Inc |
Showing 1–7 of 7 filings
Key facts
CIK
1661181
CUSIP
68621F102
13F (30d)
48 filings
48 filers
Visit website
Investor relations